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Abstract
Background: To evaluate the surgical technique using autologous retinal graft (ARG) and autologous blood clot
(ABC) for the management of refractory macular holes (MHs).
Methods: This study was a retrospective, consecutive, interventional case series. Six eyes of 6 patients who
underwent vitrectomy combined with ARG and ABC for the treatment of refractory MH were reviewed. Visual and
anatomic outcomes were evaluated.
Results: The mean age was 59.0 ± 9.9 years. All cases had multiple vitreoretinal procedures including vitrectomy
and gas fluid exchange before patient presentation. The average numbers of vitrectomies were 2.3 ± 0.5, and those
of gas fluid exchange were 3 ± 1.7. Closure of the macular hole was achieved in four (66.7%) cases at last follow-up.
The mean follow-up time was 25.2 ± 15.6 months. The averaged BCVA before and after 12 months of the surgery
improved from 20/591 to 20/244.
Conclusions: This surgical technique using ARG and ABC provide an option for the treatment of refractory MHs.
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Background
Pars plana vitrectomy combined with internal limiting
membrane (ILM) peeling and gas tamponade is consid-
ered a standard approach for treating macular holes
(MHs) [1]. The inverted ILM flap technique had been
reported to improve the success rate in difficult cases
[2]. The anatomic closure rate in a single operation
could reach nearly 90% or higher [3, 4]. Repeat fluid-gas
exchange closed most of the open holes after primary
vitrectomy with ILM peeling [5]. However, surgical
failure is still reported despite these high success rates.
Various surgical strategies have been introduced as
adjunctive procedures to attempt closure of the refractory
MH; these include enlargement of the previous ILM peel
[6], use of heavy silicone oil for tamponade [7], pedicle
ILM flap technique [8], lens capsular flap transplantation
[9], autologous free ILM flap [10–12], and autologous
neurosensory retinal free flap [13].
Autologous neurosensory retinal free flap transplant-
ation was first proposed by Grewal et al. [13], is a surgi-
cal technique used when no ILM was available to repair
the MH. And another case report was presented to show
the feasibility of using this method [14]. Although ana-
tomical success and functional improvement could be
reached, longer follow-up and larger sample sizes are
needed for further study. Also, the risk of graft disloca-
tion both intraoperatively and postoperatively remain an
issue. Our group reported a surgical approach using the
addition of autologous blood clot (ABC) appear to
improve the limitation [15]. Therefore, we combined the
autologous retinal graft (ARG) and ABC technique
together as a macular plug to increase stability and keep
the graft in place. The objective of this study was to
present the efficacy of this technique in treating refrac-
tory MHs after failed surgeries with ILM removal or
transplantation.
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Methods
This study was a retrospective, consecutive, interven-
tional case series. This ARG and ABC technique was
conducted in six patients with refractory MH by
23-gauge vitrectomy. All surgeries were performed by
one of the authors (C.-C.L.) at the Department of
Ophthalmology, Chang Gung Memorial Hospital. This
study adhered to the guidelines of the Declaration of
Helsinki and was approved by the Institutional Review
Board at Chung-Gang Memorial Hospital, Taiwan.
The inclusion criteria were as follows: (1) clinical pres-
entation of an unclosed MH after previously receiving
vitrectomy and ILM removal; (2) no remaining ILM
within the vascular arcade in the posterior pole and
treatment via combined pars plana vitrectomy with ARG
and ABC; and (3) a follow-up period of more than
1 year after the vitrectomy with ARG and ABC.
Patient records were reviewed, and the following data
were collected: age, gender, past ocular history,
preoperative best-corrected visual acuity (BCVA), and
preoperative optical coherence tomography (OCT).
Postoperative assessments were planned at 1 day,
1 week, 1 month, 3 months, 6 months, and 12 months
after surgery; then, patients were followed up every
6 months. Extra visits may occur when there is a
clinical need. BCVA and OCT were evaluated at each
follow-up visit, except on the first postoperative day
in which the fundus was prohibited from being
viewed clearly. BCVA using a Snellen chart was con-
verted to the logarithm of minimum angle of reso-
lution (logMAR) for analysis purposes.
Diagrammatic representation of surgical procedure is
outlined in Fig. 1. All cases underwent standard
23-gauge three-port, transconjunctival, sutureless micro-
incision vitrectomy (Constellation; Alcon, Fort Worth,
TX) with retrobulbar anesthesia. After the indocyanine
green (ICG) staining procedure (concentration:
0.125 mg/ml in 5% glucose water) to make sure there
was no remaining ILM within the vascular arcade in the
posterior pole, excessive ICG was immediately removed
via suction. The ARG harvest site was selected outside
the vascular arcade and facilitated by laser photocoagu-
lation in a circular manner. To achieve an effective laser
burn, full thickness retinal burns were created at differ-
ent power settings, from 200 mW to 300 mW and at dif-
ferent pulse durations, from 0.2 ms to 0.3 ms. The size
of the graft was intended to be the same as the size of
the MH and was harvested using scissors. Then, the ret-
inal graft was gently moved to be inserted into the MH.
Graft dislocation was prevented by lowering the intraoc-
ular pressure setting to reduce turbulence in the fluid
stream. Further, the position of the graft proper was
secured by trapping the edge of the graft under the edge
of the hole. After the graft was manipulated into a
proper position inside the hole, approximately 1 mL of
fresh blood obtained from the patient’s antecubital vein
was collected into a syringe, with strict attention to
aseptic precautions after disinfecting the entry site, and
allowing it to dry completely as described before [15].
One to two drops of the fresh blood were then injected
gently to cover the MH, using a back-flush needle
mounted on a 1-mL syringe. The fresh blood soon be-
came a clot on the surface of the macula, and the retina
graft and blood clot sealed the hole in a few minutes as
a macular plug. Afterwards, fluid–air exchange was
performed. If the flap was disturbed during the gas-fluid
exchange, more blood could be applied. At the end of
the operation, the air was replaced with 20% sulfur
hexafluoride gas. Patients were asked to remain face
down for one week after surgery. The key steps of this
technique are outlined in the Additional file 1.
Results
A total of six cases (six eyes in six patients: four female
and two male) with refractory MH underwent surgery
using the “ARG and ABC” technique. Characteristics of
Fig. 1 Schematic drawings showing autologous retinal graft transposition with autologous blood clot surgical technique for repairing refractory
macular holes. (a) Select the retinal graft harvest site outside the vascular arcade. White dotted circle indicates the area of an autologous retinal
graft that is facilitated by laser photocoagulation. (b) The edge of the retinal graft was cut using vertical scissors. (c) Retinal graft was obtained
and gently moved toward insertion within the macular hole. (d) Retinal graft was stabilized by placing autologous fresh blood over it. The fresh
blood soon became a clot on the surface of the macula, and the retina graft and blood clots to seal the hole in a few minutes as a macular plug
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the patients and surgical results are summarized in
Tables 1 and 2 separately. Mean age at the time of the
surgery was 59.0 ± 9.9 years. The mean basal MH size
before autologous transposition of the graft was 978.5 ±
441.0 μm. The mean minimum opening of MH was
538.0 ± 184.9 μm. In failed cases, the mean basal MH
size was 1047.5 ± 200.5 μm, and the mean minimum
opening of MH was 697.0 ± 88.0 μm before surgery. Re-
garding the pathologies of MH in our study, 4 eyes
(66.7%) were classified as idiopathic MH. And one MH
occurred after successful rhegmatogenous retinal de-
tachment surgery. The last case of MH had coexisting
history of branch retinal vein occlusion with sectoral
photocoagulation. All patients were pseudophakic at the
beginning of the study. All cases had multiple vitreoret-
inal procedures including vitrectomy and gas fluid ex-
change before patient presentation. The average number
of vitrectomies before ARG was 2.3 ± 0.5, and the aver-
age number of gas fluid exchanges was 3 ± 1.7. Closure
of the MH was achieved in four out of the six (66.7%)
patients after ARG in the study.
Intraoperatively, all eyes had successful transposition
of the ARG and no intraoperative complications related
to this technique were noted. The mean follow-up time
was 25.2 ± 15.6 months. The averaged BCVA in logMAR
before and after 12 months of the surgery were 20/591
(1.47 ± 0.31 logMAR) and 20/244 (1.09 ± 0.52 logMAR),
respectively. Overall, 4/6 eyes with a closed hole after
ARG gained visual acuity improvement, 2/6 eyes without
a closed hole remained stable, and no eyes experienced a
deterioration of the best corrected visual acuity after
ARG surgery. The blood clot could be observed approxi-
mately one week after surgery. No postoperative compli-
cations developed during the follow up period. In the
follow-up OCT, the graft appeared dislodged after the
operation and no graft tissue was visible in the two eyes
without closed holes. A reduced ellipsoid zone (EZ) line
gap with partial restoration of the external limiting
membrane and EZ was noted in one eye at last follow
up regarding the recovery of the fovea microstructure
post operatively 51 months later (Fig. 2).
Discussion
The treatment of an idiopathic macular hole could
achieve a 90% closure rate or more with a modern
vitrectomy [3, 4]. Some MH patients, such as those with
a chronic large hole, high myopia, or trauma may
require multiple surgeries. Treatment of refractory MH
became a challenging issue for macular hole closure.
Surgical management using ARG with ABC demon-
strated the efficacy of a surgical option in refractory
MHs.
The described technique may be used in patients with
refractory MHs who underwent multiple surgeries and
who had no remnant ILM. However, the closure rate of
retinal graft transplantation for refractory MHs
compares less favorably with those using ILM free flap
transplantation [10–12]. This might be partly because
anatomic success is more difficult to achieve in refrac-
tory MHs with repeated surgeries and when ILMs had
been removed. Functional recovery after surgery is
gradual and partial restoration of the external limiting
membrane and EZ could continue suggesting that the
retinal graft placed inside a macular hole may form a
bridge to repair the fovea laminar structure from the
graft edges. However, further studies are certainly
needed to investigate if ARG could not only serve as a
scaffold but also retain some function and further
promote the reparation of the outer retinal layers.
Surgical approaches for refractory MH are limited.
Improved outcomes have been reported with autolo-
gous ILM flaps [10–12]. However, harvesting a new
suitable ILM free flap can be problematic in eyes with
previous extensive ILM peeling. Lens capsular flap
transplantation may be a solution for refractory MH
when the ILM has already been removed [9]. How-
ever, the technique is not appropriate in phakic eyes
if concomitant cataract surgery is not indicated and
cannot be used in pseudophakic eyes with an open
posterior capsule. Grewal and Mahmoud described an
alternative approach involving the use of an autolo-
gous neurosensory retinal free flap for closure of re-
fractory MH [13]. The differences between their
Table 1 Characteristics of patients undergoing autologous retinal graft and blood clot for refractory macular holes











BCVA at 1 year
Follow-up
1 56 F OS 219 576 Closed Pseudophakic 20/1000 20/100 51
2 41 M OS 657 832 Closed Pseudophakic 20/400 20/200 36
3 61 M OD 389 548 Closed Pseudophakic 20/333 20/67 24
4 67 F OS 569 1820 Closed Pseudophakic 20/400 20/200 15
5 68 F OS 785 1248 Open Pseudophakic 20/400 20/400 13
6 61 F OS 609 847 Open Pseudophakic 20/2000 20/2000 12
ARG = autologous retinal graft, ABC = autologous blood clot, BCVA = best-corrected visual acuity, MH =macular hole
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procedure and ours are in considering the size of the
transplanted flap and its placement. In our surgical
procedure, we placed a similarly sized retinal graft in-
side the macular hole instead of a free larger flap
covering on it. We consider that persistent MHs close
more efficiently and promptly when graft tissue be-
comes a filler, because the tissue may serve as a scaf-
fold and a stronger bridge for glial cell proliferation.
More importantly, we hypothesized to use ABC not
only as a glue to keep the subsequently placed graft
in place and reduce the risk of graft dislocation after
the surgery, but also as a potential autologous adju-
vant to augmenting the healing processes [15]. Add-
itionally, the mixture of ARG and ABC formed a
macular plug that sealed the MH shortly after appli-
cation. This may maintain the dryness of the MH,
prevent vitreous fluid from moving into the defect,
and thereby ensure that the glial proliferation and mi-
gration closes the hole completely theoretically. How-
ever, further study is needed to arrive at a definitive
conclusion of the mechanism.
The most difficult part of the transposition of the
retinal graft technique is the transferring procedure
from the harvest site to precisely insert the graft in-
side the macular hole. Grewal and Mahmoud devel-
oped the Perfluoro-n-octane heavy liquid (PFC)
(Perfluoron; Alcon) assisted neurosensory retinal free
flap transposition technique in their case [13]. The
tamponade effect from the PFC could prevent the
graft from floating away on intraocular currents dur-
ing surgery before direct PFC–silicone oil exchange.
Fig. 2 Results of autologous retinal graft and blood clot in a 55-year-old refractory macular hole patient. Despite 4 pars plana vitrectomies with
ILM peeling and additional 5 gas-fluid exchanges, spectral domain optical coherence tomography images (SD-OCT) showed the hole persisting
(a). The base diameter of the MH before the retinal graft transplantation was 576 μm, and the minimum opening of the MH size was 219 μm.
After the procedure, the macular hole was successfully closed at 3 months (b) and 12 months (c). The fovea remained stable and the patient’s
visual acuity improved from 20/1000 before the surgery to 20/100 at the final visit. SD-OCT imaging (d) and fundus photograph (e) obtained at
51 months postoperatively. SD-OCT showing partial restoration of external limiting membrane and gradually reconstructed ellipsoid zone
(black arrowhead)
Table 2 Demographics and surgical results among all cases (n = 6)
Factor
Male/Female (no.) 2/4
Age (yrs) 59.0 ± 9.9
Idiopathic MH, no. (%) 4 (66.7)
Axial length (mm) 25.63 ± 1.76
Follow-up (months) 25.2 ± 15.6
Basal MH size (μm) 978.5 ± 441.0
Minimum opening of MH (μm) 538.0 ± 184.9
Basal MH size in failed cases (μm) 1047.5 ± 200.5
Minimum opening of MH in failed cases (μm) 697.0 ± 88.0
Preoperative BCVA (logMAR) 20/591 (1.47 ± 0.31)
Postoperative BCVA (logMAR)
1 mo 20/691 (1.54 ± 0.41)
3 mos 20/342 (1.23 ± 0.27)
6 mos 20/310 (1.19 ± 0.44)
12 mos 20/244 (1.09 ± 0.52)
BCVA at last visit, no. (%)
Improved 4 (66.7)
No change 2 (33.3)
Worse 0 (0)
MH closed, no. (%) 4 (66.7)
BCVA = best-corrected visual acuity, logMAR = logarithm of the minimum angle
of resolution, MH =macular hole
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In contrast to their method, we found that the ARG
tissue could be mechanically tucked and positioned
inside the MH until completion of the autologous
blood clot. However, the most important point during
this procedure is to avoid potential iatrogenic trauma
to the fovea tissue.
In this series, the aspiration of fluid was slowly per-
formed via fluid-air exchange, and we did not per-
form further fluid aspiration after a 5 to 10-min wait
after the initial fluid-air exchange to maximize vitre-
ous cavity dehydration [16, 17]. Further, there is no
need to aspirate the last drop of vitreous cavity fluid
in avoidance of disturbing to the macular plug; this is
because the hole is, theoretically, temporarily sealed
after blood clot formation. And further gas tampon-
ade is important to maintaining the dryness of the
macula, which prevents the vitreous fluid from mov-
ing into the hole, and ensures that the retinal graft
can be placed inside the MH as a bridge to help the
repair process.
Graft dislocation was detected by OCT one month
postoperatively in our two failure cases. The patients
declined to receive any further treatment, however,
the visual acuity revealed no deterioration after the
surgery. We noted that these two cases were idio-
pathic MHs and the hole size was larger than the
other four cases preoperatively. Given that hole and
graft size cannot be accurately measured intraopera-
tively, the graft prepared may not have been large
enough to fill the whole MH. Additionally, a shrinkage
of the graft tissue may happen when cutting a graft, or
contracture may occur during the healing process. In this
situation, it was difficult to secure the graft tissue under
the hole margin, causing graft dislodgement during the
postoperative period. Regarding the toxicity issues due to
blood products and fibrin degradation products used in
this technique [18], although blood may leak into the
subretinal space and cause damage to the photorecep-
tors, safety concerns are reduced because the graft
tissue barrier serves as a filler at the hole. Although
this study contains the postoperative visual acuity,
further study measuring electroretinogram and micro-
perimetry may provide more information regarding
the functional outcomes.
Conclusion
Management of refractory MH presents a surgical chal-
lenge. ARG and ABC technique may be used in cases of
refractory MH who have undergone multiple surgeries,
and where no remnant ILM is present within the arcade
vessels. Also, this surgical technique had a positive effect
on visual function in all of the closure cases. Further
study in a larger population that directly compares this
technique with other techniques is warranted.
Additional file
Additional file 1: Video that illustrates key steps of autologous retinal
graft and blood clot technique for the management of refractory macular
holes. (MP4 17160 kb)
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